• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全身 MRI 的多变量预测模型在前列腺癌骨转移评估中的应用。

Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.

机构信息

Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, 800 Xiangyin Road, Shanghai, 200433, China.

Department of Imaging, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.

出版信息

World J Urol. 2021 Aug;39(8):2937-2943. doi: 10.1007/s00345-020-03571-8. Epub 2021 Feb 1.

DOI:10.1007/s00345-020-03571-8
PMID:33521882
Abstract

PURPOSE

A whole-body MRI (WB-MRI) including T1, short time inversion recovery (STIR), diffusion-weighted imaging (high b value) was applied in our center for the detection of bone metastasis in prostate cancer (PCa) patients. We intended to assess the diagnostic performance of this examination.

METHODS

547 cases of PCa patients with higher risk of metastasis were referred to bone scintigraphy with SPECT/CT (BS + SPECT/CT) and whole-body MRI in Shanghai Changhai Hospital. Best valuable comparator (BVC) was applied for the final diagnosis of metastasis. A panel of radiologists interpreted the results. Decision curve analysis (DCA) and receiver operating characteristic curve (ROC) analysis were applied.

RESULTS

Bone metastasis was diagnosed in 110 cases, and others were non-metastatic by BVC. The area under the receiver operating characteristic curve (AUC) was higher in WB-MRI (0.778) than BS + SPECT/CT (0.634, p < 0.001). A WB-MRI-based prediction model was established with AUC of 0.877. Internal validation showed that the predictive model was well-calibrated. The DCA demonstrated that the model had higher net benefit than the BS + SPECT/CT-based model.

CONCLUSION

WB-MRI is more effective in identifying metastasis in PCa patients than BS + SPECT/CT. The prediction model combined WB-MRI with clinical parameters may be a promising approach to the assessment of metastasis.

摘要

目的

本研究中心采用全身 MRI(WB-MRI)平扫联合 T1 加权成像、短时间反转恢复序列(STIR)、弥散加权成像(高 b 值),用于检测前列腺癌(PCa)患者的骨转移情况。本研究旨在评估该检查的诊断性能。

方法

上海长海医院对 547 例有较高转移风险的 PCa 患者进行全身骨扫描 SPECT/CT(BS+SPECT/CT)和全身 MRI 检查。采用最佳对比值(BVC)作为最终诊断转移的金标准。由一组放射科医生对结果进行解读。本研究采用决策曲线分析(DCA)和受试者工作特征曲线(ROC)分析。

结果

BS+SPECT/CT 诊断为骨转移的患者有 110 例,BVC 诊断为非转移的患者有 437 例。WB-MRI 的 ROC 曲线下面积(AUC)高于 BS+SPECT/CT(0.778 比 0.634,p<0.001)。建立基于 WB-MRI 的预测模型,AUC 为 0.877。内部验证显示,该预测模型具有良好的校准度。DCA 表明,该模型的净获益高于基于 BS+SPECT/CT 的模型。

结论

与 BS+SPECT/CT 相比,WB-MRI 更有助于识别 PCa 患者的转移病灶。WB-MRI 联合临床参数的预测模型可能是评估转移的一种很有前途的方法。

相似文献

1
Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.基于全身 MRI 的多变量预测模型在前列腺癌骨转移评估中的应用。
World J Urol. 2021 Aug;39(8):2937-2943. doi: 10.1007/s00345-020-03571-8. Epub 2021 Feb 1.
2
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?全身磁共振弥散加权成像能否替代 Tc 99m 骨扫描和 CT 进行高危前列腺癌患者的一步法转移检测?
Eur Urol. 2012 Jul;62(1):68-75. doi: 10.1016/j.eururo.2012.02.020. Epub 2012 Feb 17.
3
Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.全身 MRI 评估前列腺癌和多发性骨髓瘤的骨骼受累:T1、短 tau 反转恢复(STIR)和高 b 值扩散加权成像(DWI)序列的诊断准确性比较。
Eur Radiol. 2019 Aug;29(8):4503-4513. doi: 10.1007/s00330-018-5796-1. Epub 2018 Nov 9.
4
Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.多参数全身 3.0-T MRI 在新诊断的中高危前列腺癌中的应用:用于淋巴结和转移分期的诊断准确性和观察者间一致性。
Eur Radiol. 2019 Jun;29(6):3159-3169. doi: 10.1007/s00330-018-5813-4. Epub 2018 Dec 5.
5
3D SPECT/CT fusion using image data projection of bone SPECT onto 3D volume-rendered CT images: feasibility and clinical impact in the diagnosis of bone metastasis.利用骨SPECT图像数据投影到三维容积再现CT图像上进行三维SPECT/CT融合:在骨转移瘤诊断中的可行性及临床影响
Ann Nucl Med. 2017 May;31(4):304-314. doi: 10.1007/s12149-017-1158-3. Epub 2017 Feb 27.
6
Rationale for Modernising Imaging in Advanced Prostate Cancer.在晚期前列腺癌中进行影像学现代化的理由。
Eur Urol Focus. 2017 Apr;3(2-3):223-239. doi: 10.1016/j.euf.2016.06.018. Epub 2016 Jul 15.
7
Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.用于检测转移性骨肿瘤的全身磁共振成像:与骨闪烁显像的比较
Magn Reson Med Sci. 2005;4(1):11-7. doi: 10.2463/mrms.4.11.
8
Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer.全身 MRI:一种强大的无辐射和钆增强剂骨髓分期替代骨扫描的方法。
Clin Transl Oncol. 2020 Aug;22(8):1321-1328. doi: 10.1007/s12094-019-02257-x. Epub 2019 Dec 19.
9
Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.前列腺癌患者的诊断性骨成像:患者对NaF-PET/CT、胆碱-PET/CT、全身MRI和骨SPECT/CT的体验与接受度
Acta Radiol. 2018 Sep;59(9):1119-1125. doi: 10.1177/0284185117751280. Epub 2018 Jan 9.
10
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.前列腺癌转移报告与数据系统:基于全身磁共振成像的晚期前列腺癌多器官受累评估的采集、解读及报告实用指南
Eur Urol. 2017 Jan;71(1):81-92. doi: 10.1016/j.eururo.2016.05.033. Epub 2016 Jun 14.

引用本文的文献

1
Prostate cancer and bone: clinical presentation and molecular mechanisms.前列腺癌与骨骼:临床表现与分子机制。
Endocr Relat Cancer. 2023 Jul 25;30(9). doi: 10.1530/ERC-22-0360. Print 2023 Sep 1.
2
Unambiguous radiologic extranodal extension determined by MRI could be a biomarker in predicting metastatic prostate cancer.由MRI确定的明确的放射学结外扩展可能是预测转移性前列腺癌的生物标志物。
Radiol Med. 2023 May;128(5):520-527. doi: 10.1007/s11547-023-01631-8. Epub 2023 Apr 26.